Ozmosi Launches a Global Clinical Trials Database.
M2 PHARMA-September 11, 2017-Ozmosi Launches a Global Clinical Trials Database
(C)2017 M2 COMMUNICATIONS
- US-based competitive intelligence and forecasting solutions company Ozmosi has launched a new global website which consolidates clinical trial data from all around the world into a single searchable database, GlobalClinicalTrialsData.com, the company said.
The company said that, with the solution, anyone can use this free, real-time, global resource to search more than 280,000 trials covering over 3,700 disease areas to better understand and explore clinical trials in the pharmaceutical industry.
By delivering a website that aggregates real-time trial data from clinical trial registries around the world into one single, easy-to-use publicly available website, Ozmosi said it has taken several large steps toward providing the industry and patients with ten times more downloadable clinical information than any other existing free global registry.
Ozmosi said its database offers unfettered access to more downloadable clinical trial information, a more intuitive user interface, coupled with real-time updates from international registries, dramatically reducing the amount of time spent on aggregating clinical trial data from around the world.
((Comments on this story may be sent to email@example.com))
|Printer friendly Cite/link Email Feedback|
|Date:||Sep 11, 2017|
|Previous Article:||Amgen, Allergan Present Phase 3 Data On Biosimilar Trastuzumab Candidate ABP 980.|
|Next Article:||Pfizer Presents Overall Survival Data of Xalkori in Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer.|